{"nct_id":"NCT02013167","title":"Blinatumomab Versus Standard of Care Chemotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)","status":"TERMINATED","status_verified_date":"2024-03","start_date":"2014-01-03","start_date_type":"ACTUAL","primary_completion_date":"2015-12-29","primary_completion_date_type":"ACTUAL","completion_date":"2017-03-14","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}